Lutetium-177 (Lu-177) Market is Segmented by Type (Non-carrier-added, Carrier-added), by Application (Nuclear Therapy, Others). The Lutetium-177 market is poised for significant expansion as demand ...

Discover comprehensive details about Lutetium Lu 177 Dotatate, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it. The updated ...

The appraisal committee considered evidence from a number of sources. See the committee papers for full details of the evidence. The committee understood that neuroendocrine tumours (NETs) can affect ...

• Lutetium Lu 177 dotatate comes as a liquid which should be administered intravenously using a particular technique by trained healthcare personnel. • Lutetium Lu 177 dotatate is slowly infused along ...

Garching / Munich, Germany – October 13, 2022 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced the successful completion of a new production ...

TRIUMPH: Phase II trial of rucaparib monotherapy in patients with metastatic hormone-sensitive prostate cancer harboring germline DNA repair gene mutations. This is an ASCO Meeting Abstract from the ...

ONTARIO, Canada & MUNICH, Germany--(BUSINESS WIRE)--ITM Medical Isotopes GmbH and Isogen signed a formal supply arrangement to provide a reliable supply of Lutetium-177 to the world’s health care ...

IN connexion with the half-life standardization of lutetium-176 (half-life = 2.2 × 2 10 yr.) a 1-g quantity of commercially available lutetium oxide was obtained having a purity of 99.9 per cent.

GARCHING / MUNICH, Germany and INDIANAPOLIS, July 31, 2023 (GLOBE NEWSWIRE) -- ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company and POINT Biopharma Global Inc.